Common use of Subsequent Equity Sales Clause in Contracts

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafter, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 8 contracts

Samples: Underwriting Agreement (Dolphin Entertainment, Inc.), Underwriting Agreement (Airborne Wireless Network), Underwriting Agreement (Dolphin Entertainment, Inc.)

AutoNDA by SimpleDocs

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 8 contracts

Samples: Securities Purchase Agreement (Creatd, Inc.), Securities Purchase Agreement (Creatd, Inc.), Securities Purchase Agreement (Motus GI Holdings, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 7 contracts

Samples: Securities Purchase Agreement (Rocketfuel Blockchain, Inc.), Securities Purchase Agreement (BioSolar Inc), Securities Purchase Agreement (Predictive Oncology Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterfollowing the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 7 contracts

Samples: Securities Purchase Agreement (Oncocyte Corp), Form of Securities Purchase Agreement (Blue Water Vaccines Inc.), Securities Purchase Agreement (NextPlat Corp)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 7 contracts

Samples: Securities Purchase Agreement (Mobile Global Esports, Inc.), Securities Purchase Agreement (ASP Isotopes Inc.), Securities Purchase Agreement (WeTrade Group Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 5 contracts

Samples: Securities Purchase Agreement (Fibrocell Science, Inc.), Securities Purchase Agreement (UFood Restaurant Group, Inc.), Securities Purchase Agreement (Vu1 CORP)

Subsequent Equity Sales. (a) From Except with respect to the issuances described on Schedule 4.13 hereto, from the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 5 contracts

Samples: Securities Purchase Agreement (Ensysce Biosciences, Inc.), Securities Purchase Agreement (Ensysce Biosciences, Inc.), Securities Purchase Agreement (Allied Esports Entertainment, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement

Appears in 4 contracts

Samples: Securities Purchase Agreement (Dermata Therapeutics, Inc.), Securities Purchase Agreement (Vivos Therapeutics, Inc.), Securities Purchase Agreement (Iveda Solutions, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty the date that is six (606) days hereaftermonths following the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 4 contracts

Samples: Securities Purchase Agreement (Iconic Brands, Inc.), Securities Purchase Agreement (Iconic Brands, Inc.), Securities Purchase Agreement (Iconic Brands, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterfollowing the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (MMEX Resources Corp), Securities Purchase Agreement (Healthcare Triangle, Inc.), Securities Purchase Agreement (Clearone Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, other than the Prospectus Supplement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Orbital Energy Group, Inc.), Securities Purchase Agreement (Orbital Energy Group, Inc.), Securities Purchase Agreement (Orbital Energy Group, Inc.)

Subsequent Equity Sales. (a) From Except as provided in paragraph (c) below, from the date hereof until sixty (60) 120 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents pursuant to which a Person is entitled to acquire shares of Common Stock at an effective price per share that is less than $3.25.

Appears in 3 contracts

Samples: Securities Purchase Agreement (BioSig Technologies, Inc.), Securities Purchase Agreement (BioSig Technologies, Inc.), Securities Purchase Agreement (BioSig Technologies, Inc.)

Subsequent Equity Sales. (ai) From the date hereof until sixty (60) 180 days hereafterfollowing the date hereof, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents.. For the purposes hereof, “

Appears in 3 contracts

Samples: Underwriting Agreement (Therapix Biosciences Ltd.), Underwriting Agreement (Therapix Biosciences Ltd.), Underwriting Agreement (Therapix Biosciences Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 120 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents; provided, however, if such issuance is in connection with an up-listing to a “national securities exchange” as defined in Rule 600(b) of Regulation NMS, such issuance may occur at any time after the Reverse Stock Split Date.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Delcath Systems, Inc.), Securities Purchase Agreement (Delcath Systems, Inc.), Share Purchase Agreement (Edison Nation, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days hereafterafter the Effective Date (such applicable period, the “Restricted Period”), neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents(ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Delcath Systems, Inc.), Securities Purchase Agreement (Delcath Systems, Inc.), Securities Purchase Agreement (Delcath Systems, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty twelve (6012) days hereaftermonths, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.

Appears in 3 contracts

Samples: Underwriting Agreement (Virax Biolabs Group LTD), Underwriting Agreement (Virax Biolabs Group LTD), Underwriting Agreement (Virax Biolabs Group LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement

Appears in 3 contracts

Samples: Securities Purchase Agreement (Creative Medical Technology Holdings, Inc.), Securities Purchase Agreement (NewAge, Inc.), Securities Purchase Agreement (BigBear.ai Holdings, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents.

Appears in 3 contracts

Samples: Securities Purchase Agreement (BioLineRx Ltd.), Securities Purchase Agreement (BioLineRx Ltd.), Securities Purchase Agreement (Safe-T Group Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Phio Pharmaceuticals Corp.), Securities Purchase Agreement (Caladrius Biosciences, Inc.), Securities Purchase Agreement (Citius Pharmaceuticals, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 45 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Biofrontera Inc.), Securities Purchase Agreement (Movano Inc.), Securities Purchase Agreement (Cancer Genetics, Inc)

Subsequent Equity Sales. (ai) From the date hereof until the date that is sixty (60) days hereafterfollowing the date hereof, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 3 contracts

Samples: Underwriting Agreement (ImmunoCellular Therapeutics, Ltd.), Underwriting Agreement (Immune Pharmaceuticals Inc), Underwriting Agreement (Immune Pharmaceuticals Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents without the prior written approval of the Preferred Director (as defined in Section 4.18).

Appears in 3 contracts

Samples: Securities Purchase Agreement (MICT, Inc.), Form of Securities Purchase Agreement (BNN Technology PLC), Securities Purchase Agreement (MICT, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty one hundred eighty (60180) days hereafterfollowing the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, (ii) file any registration statement or any amendment or supplement thereto, in each case other than the Prospectus or (iii) amend, modify or waiver the terms of any securities outstanding on the date hereof.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Ontrak, Inc.), Securities Purchase Agreement (Ontrak, Inc.), Securities Purchase Agreement (Ontrak, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, other than (A) the Prospectus Supplement and (B) the registration statement referred in Section 4.16 of this Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Summit Wireless Technologies, Inc.), Securities Purchase Agreement (Summit Wireless Technologies, Inc.), Securities Purchase Agreement (Summit Wireless Technologies, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafter90 Trading Days following the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents. Notwithstanding the foregoing, this Section 4.19 shall not apply in respect of (x) an Exempt Issuance or (y) any filing by the Company of a registration statement, prospectus or other document with the Commission or related announcement pursuant to the Investors’ Rights Agreement or the Registration Rights Agreement.

Appears in 2 contracts

Samples: Underwriting Agreement (Ceres, Inc.), Underwriting Agreement (Ceres, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Rosetta Genomics Ltd.), Securities Purchase Agreement (Rosetta Genomics Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall not issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents without Majority Approval.

Appears in 2 contracts

Samples: Securities Purchase Agreement (VerifyMe, Inc.), Securities Purchase Agreement (VerifyMe, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the anniversary of the date of this Agreement, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Grom Social Enterprises, Inc.), Securities Purchase Agreement (Grom Social Enterprises, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Peraso Inc.), Securities Purchase Agreement (Peraso Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement. Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance or the filing of a universal shelf registration statement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (BBQ Holdings, Inc.), Securities Purchase Agreement (BBQ Holdings, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents without the written approval of the Purchasers of 50.1% or greater of the Securities issued hereunder, based on initial Subscription Amounts hereunder.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Inspyr Therapeutics, Inc.), Securities Purchase Agreement (Inspyr Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Coretec Group Inc.), Securities Purchase Agreement (Innovative Payment Solutions, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty 30 days after the Effective Date (60) days hereafterthe “Lock-Up Period”), neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement for Units (Tenax Therapeutics, Inc.), Securities Purchase Agreement for Units (Tenax Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Biofrontera Inc.), Securities Purchase Agreement (Intec Parent Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, other than the Prospectus Supplement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Celularity Inc), Securities Purchase Agreement (Celularity Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty six (606) days hereaftermonths after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents without the prior written consent of the Representative.

Appears in 2 contracts

Samples: Underwriting Agreement (Xenetic Biosciences, Inc.), Underwriting Agreement (Xenetic Biosciences, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterthe 180th day following the IPO Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Bluejay Diagnostics, Inc.), Securities Purchase Agreement (Smart for Life, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Actelis Networks Inc), Securities Purchase Agreement (Odyssey Health, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Arcimoto Inc), Securities Purchase Agreement (Silo Pharma, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement

Appears in 2 contracts

Samples: Securities Purchase Agreement (Brooklyn ImmunoTherapeutics, Inc.), Securities Purchase Agreement (BlackSky Technology Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 180 days hereafterfollowing the Execution Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents.

Appears in 2 contracts

Samples: Underwriting Agreement (CardieX LTD), Underwriting Agreement (Cellect Biotechnology Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock EquivalentsShare Equivalents without the prior written consent of the Representative.

Appears in 2 contracts

Samples: Underwriting Agreement (Castor Maritime Inc.), Underwriting Agreement (Castor Maritime Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement or to register for resale the shares underlying the Company’s outstanding warrants.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Northern Lights Acquisition Corp.), Securities Purchase Agreement (SHF Holdings, Inc.)

Subsequent Equity Sales. (a) From Without the prior consent of the Placement Agents or the Purchasers representing a majority of the aggregate Subscription Amount in this offering, from the date hereof until sixty (60) 60 days hereafterafter the date hereof, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, except for any at-the-market offerings or equity lines of credit or in connection with any strategic collaboration.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Better Therapeutics, Inc.), Securities Purchase Agreement (Better Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the Closing Date until the date hereof until sixty that is thirty (6030) trading days hereafterthereafter, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of (i) Common Stock Shares or Common Stock EquivalentsShare Equivalents or (ii) convertible debt securities (and underlying shares upon the conversion thereof) to any of the officers (or their affiliated entities) or directors of the Company, without the prior written consent of the Representative.

Appears in 2 contracts

Samples: Underwriting Agreement (Intellipharmaceutics International Inc.), Underwriting Agreement (Cesca Therapeutics Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty six (606) days hereaftermonths, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or file any registration statement or supplement or amendment thereto (other than in connection with this offering).

Appears in 2 contracts

Samples: Underwriting Agreement (Cyclo Therapeutics, Inc.), Cyclo Therapeutics, Inc.

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as (i) contemplated pursuant to the Registration Rights Agreement or (ii) necessary to maintain the effectiveness of existing registration statements which are effective as of the Effective Date.

Appears in 2 contracts

Samples: Securities Purchase Agreement (GeoVax Labs, Inc.), Securities Purchase Agreement (VerifyMe, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement to any registration statement, except for the Prospectus Supplement on Form 424 in connection with the transaction contemplated hereby.

Appears in 2 contracts

Samples: Securities Purchase Agreement (AMERI Holdings, Inc.), Securities Purchase Agreement (CHF Solutions, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing, neither the Company nor any Subsidiary subsidiary shall (i) issue, enter into any agreement to issue issue, or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents, or (ii) file or amend any registration statement or prospectus, other than as necessary to maintain the registration of the Securities governed by this Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (SuperCom LTD), Securities Purchase Agreement (SuperCom LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the effectiveness of the Registration Statement, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement. Notwithstanding the foregoing, this Section 4.10 shall not apply in respect of any Exempt Issuances.

Appears in 1 contract

Samples: Securities Purchase Agreement (Abeona Therapeutics Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock EquivalentsShares Equivalents or (ii) file any registration statement or any amendment or supplement thereto, except as required to be filed pursuant to the Registration Rights Agreement. Notwithstanding the foregoing, this Section 4.20 shall not apply in respect of an Exempt Issuance.

Appears in 1 contract

Samples: Securities Purchase Agreement (BriaCell Therapeutics Corp.)

Subsequent Equity Sales. (ai) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to this Agreement.

Appears in 1 contract

Samples: Hepion Pharmaceuticals, Inc.

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock EquivalentsOrdinary Shares Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Diginex LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement or a Form S-8 to register securities under the Company’s stock option plan.

Appears in 1 contract

Samples: Securities Purchase Agreement (UpHealth, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement. Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance.

Appears in 1 contract

Samples: Securities Purchase Agreement (ASP Isotopes Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than (a) as contemplated pursuant to the Registration Rights Agreement or (b) the filing of a registration statement, including any amendment or supplement thereto, on Form S-8.

Appears in 1 contract

Samples: Securities Purchase Agreement (Essetifin SPA)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement or a post-effective amendment to an existing registration statement necessary to continue such registration without lapse.

Appears in 1 contract

Samples: Securities Purchase Agreement (Agrify Corp)

Subsequent Equity Sales. (ai) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to this Agreement.

Appears in 1 contract

Samples: Motus GI Holdings, Inc.

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterfrom the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares ADSs, Ordinary Shares or Ordinary Shares Equivalents or file any registration statement or any amendment or supplement thereto, except that the Company may enter into a public or private offering of Common Stock or Common Stock Equivalentsconvertible debt involving a Variable Rate Transaction of up to $800,000 (the “Exempt Offering”).

Appears in 1 contract

Samples: Securities Purchase Agreement (Dunxin Financial Holdings LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement or filing a registration statement on Form S-8 in connection with any employee benefit plan.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cadrenal Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, including, without limitation, the filing of a registration statement or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (ZW Data Action Technologies Inc.)

AutoNDA by SimpleDocs

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, other than the Prospectus Supplement and the registration statement contemplated pursuant to Section 4.17 below.

Appears in 1 contract

Samples: Securities Purchase Agreement (Atossa Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 calendar days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement or any amendments to registration statements filed prior to the date of this Agreement so long as no new securities are registered on any such existing registration statements.

Appears in 1 contract

Samples: Securities Purchase Agreement (Intelligent Bio Solutions Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock EquivalentsOrdinary Shares Equivalents (each, a “Subsequent Placement”).

Appears in 1 contract

Samples: Securities Purchase Agreement (Luokung Technology Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, other than as contemplated pursuant to the Registration Rights Agreement or filing a registration statement on Form S-8 in connection with any employee benefit plan.

Appears in 1 contract

Samples: Securities Purchase Agreement (Toughbuilt Industries, Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterthe Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Creek Road Miners, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than (A) as contemplated pursuant to the Registration Rights Agreement or (B) the filing of a registration statement on Form S-8.

Appears in 1 contract

Samples: Securities Purchase Agreement (Apexigen, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement, and other than a prospectus supplement to be filed in connection with the Registered Direct or the filing of a registration statement or any amendment thereto with respect to the Warrant Amendment.

Appears in 1 contract

Samples: Securities Purchase Agreement (Enveric Biosciences, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock Equivalents.Shares Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement

Appears in 1 contract

Samples: Securities Purchase Agreement (Very Good Food Co Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty the later of (60i) 60 days hereafterafter the Effective Date, and (ii) 60 days after “Shareholder Approval” (as defined in the Private Placement SPA) is obtained, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 1 contract

Samples: Securities Purchase Agreement (Bridgeline Digital, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 120 days hereafterafter the date hereof, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock EquivalentsOrdinary Share Equivalents or (ii) file any registration statement or any amendment or supplement thereto.

Appears in 1 contract

Samples: Securities Purchase Agreement (Fangdd Network Group Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement

Appears in 1 contract

Samples: Securities Purchase Agreement (Staffing 360 Solutions, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty the later of (60x) 30 days hereafterafter the Effective Date or (y) the day the Company obtains the Stockholder Approval, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (AzurRx BioPharma, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafter15 Trading Days after the registration of the Warrants pursuant to an effective registration statement filed under the Securities Act, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock Share Equivalents.

Appears in 1 contract

Samples: Securities Purchase Agreement (Top Ships Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty the date that is six (606) days hereaftermonths following the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents without the prior written consent of the Purchaser.

Appears in 1 contract

Samples: Securities Purchase Agreement (GTX Corp)

Subsequent Equity Sales. (a) From the date hereof until sixty six (606) days hereaftermonths after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated by this Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Inhibikase Therapeutics, Inc.)

Subsequent Equity Sales. (a) From Subject to Section 4.11(c), from the date hereof until sixty ninety (6090) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than the Prospectus Supplement or the filing of a registration statement or any amendment thereto with respect to the Preferred Investment Option Shares and the Private Placement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Polarityte, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty five (6045) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, except for issuances of Common Stock priced at a price per share of Common Stock in excess of 110% of the Per Share Purchase Price.

Appears in 1 contract

Samples: Securities Purchase Agreement (AzurRx BioPharma, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty 60 (60sixty) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto.

Appears in 1 contract

Samples: Securities Purchase Agreement (Citius Pharmaceuticals, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock EquivalentsOrdinary Share Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (TC BioPharm (Holdings) PLC)

Subsequent Equity Sales. (a) From the date hereof until sixty twenty five (6025) calendar days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement (the "Lock-Up Period”).

Appears in 1 contract

Samples: Securities Purchase Agreement (Kalera Public LTD Co)

Subsequent Equity Sales. (a) From Without the prior consent of the Placement Agent or the Purchasers representing a majority of the aggregate Subscription Amount in this offering, from the date hereof until sixty (60) 60 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, except for any at-the-market offerings or equity lines of credit or in connection with any strategic collaboration.

Appears in 1 contract

Samples: Securities Purchase Agreement (Better Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until the later of (i) sixty (60) days hereafterafter the Effective Date, and (ii) sixty (60) days after the “Shareholder Approval” (as defined in this Agreement) is obtained, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or equity of the Company or any Subsidiary, or (ii) file any registration statement or any amendment or supplement thereto on behalf of the Company or any Subsidiary, in each case other than as permitted pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Bridgeline Digital, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafter, after the effective date of the Resale Registration Statement neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 1 contract

Samples: Exchange Agreement (authID Inc.)

Subsequent Equity Sales. (a) From the date hereof Effective Date until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, except a registration statement on Form S-8. Notwithstanding the foregoing, this Section 4.17 shall not apply in respect of an Exempt Issuance.

Appears in 1 contract

Samples: Securities Purchase Agreement (LMP Automotive Holdings, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement

Appears in 1 contract

Samples: Securities Purchase Agreement (Smart for Life, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 180 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cleantech Acquisition Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty the later of (60x) 90 days hereafterafter the Effective Date or (y) the Authorized Share Increase Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cytrx Corp)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock EquivalentsOrdinary Shares Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (CYREN Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares ADS, Ordinary Shares or Ordinary Shares Equivalents, (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement or (iii) undertake any exchange for equity of Common Stock or Common Stock Equivalentsthe Company, including warrants and options with a lower exercise price.

Appears in 1 contract

Samples: Securities Purchase Agreement (Lion Group Holding LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterfollowing the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents. Notwithstanding the foregoing, this Section 4.20 shall not apply in respect of (x) an Exempt Issuance or (y) any filing by the Company of a registration statement, prospectus or other document with the Commission or related announcement pursuant to the Investors’ Rights Agreement or the Registration Rights Agreement.

Appears in 1 contract

Samples: Underwriting Agreement (Ceres, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 45 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement. Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance.

Appears in 1 contract

Samples: Securities Purchase Agreement (Presto Automation Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue offer, sell, issue, or otherwise transfer or dispose of, directly or indirectly, or announce the issuance foregoing or proposed issuance of any shares of capital stock of the Company or Common Stock Equivalents; or (ii) file or caused to be filed any registration statement with the Commission relating to the offering of any shares of capital stock of the Company or Common Stock Equivalents.

Appears in 1 contract

Samples: Engagement Agreement (Telemynd, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than the Prospectus Supplement or the filing of a registration statement or any amendment thereto with respect to the Preferred Investment Option Shares and the Private Placement and the Warrant Amendment.

Appears in 1 contract

Samples: Securities Purchase Agreement (Enveric Biosciences, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty fourteen (6014) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement (including the filing of the Universal Shelf (as defined therein) contemplated thereby).

Appears in 1 contract

Samples: Securities Purchase Agreement (Exela Technologies, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 45 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement, other than a Registration Statement on Form S-4 in connection with the redomestication of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (SharpLink Gaming Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterfollowing the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement or filing a registration statement on Form S-8 in connection with any employee compensation plan.

Appears in 1 contract

Samples: Securities Purchase Agreement (Lipella Pharmaceuticals Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto. Notwithstanding the foregoing, this Section 4.12(a) may be waived in writing with the prior written consent of a majority in interest of the Purchasers hereunder (based on Subscription Amounts hereunder).

Appears in 1 contract

Samples: Securities Purchase Agreement (Crown Electrokinetics Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, except for Exempt Issuances.

Appears in 1 contract

Samples: Securities Purchase Agreement (GeoVax Labs, Inc.)

Subsequent Equity Sales. (ai) From the date hereof until sixty forty-five (6045) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to this Agreement.

Appears in 1 contract

Samples: Vivos Therapeutics, Inc.

Time is Money Join Law Insider Premium to draft better contracts faster.